Estimated Burden of Coccidioidomycosis

By sjmartinez • June 4, 2025

Williams SL, Benedict K, Jackson BR, Rajeev M, Cooksey G, Ruberto I, Williamson T, Sunenshine RH, Osborn B, Oltean HN, Reik RR, Freedman MS, Spec A, Carey A, Schwartz IS, Medina-Garcia L, Bahr NC, Kuran R, Heidari A, Thompson GR 3rd, Johnson R, Galgiani JN, Chiller T, Toda M. Estimated Burden of Coccidioidomycosis. JAMA Netw Open. 2025 Jun 2;8(6):e2513572. doi: 10.1001/jamanetworkopen.2025.13572. PMID: 40459889.

Tags: Infectious Diseases, Kern, Publications

Ibalizumab plus an optimized background regimen in treatment-experienced patients infected with multidrug resistant HIV-1: A phase 3, multicenter, expanded access study

Emu B, Kumar PN, Mills A, Berhe M, Cash BR, Kuo KL, Anstett K. Ibalizumab plus an optimized background regimen in treatment-experienced patients infected with[...]

Barriers to viral suppression in children aged 9 years or younger on dolutegravir-based antiretroviral therapy in Malawi, a mixed-methods study

Phiri K, Hagstrom C, Lungu E, Balakasi K, Songo J, Makwaya A, Smith D, Worku A, Hoffman R, Phiri S, Dovel K, van Oosterhout JJ.[...]

Single-cell analyses identify monocyte gene expression profiles that influence HIV-1 reservoir size in acutely treated cohorts

Ehrenberg PK, Geretz A, Volcic M, Izumi T, Yum LK, Waickman A, Shangguan S, Paquin-Proulx D, Creegan M, Bose M, Machmach K, McGraw A, Narahari[...]